Association of prognostic value of primary tumor location in stage III colon cancer with RAS and BRAF mutational status.

Authors

Julien Taieb

Julien Taieb

Hopital Européen Georges Pompidou, Paris, France

Julien Taieb , Hampig Raphael Kourie , Jean-François Emile , Karine Le Malicot , Ralyath Balogoun , Josep Tabernero , Enrico Mini , Gunnar Folprecht , Jean-Luc Van Laethem , Claire Mulot , Olivier Bouche , Thomas Aparicio , Pierre Michel , Josef Thaler , John A. Bridgewater , Eric Van Cutsem , Géraldine Perkins , Ramon Salazar , Come Lepage , Pierre Laurent-Puig

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

2005-003463-23

Citation

J Clin Oncol 35, 2017 (suppl; abstr 3515)

DOI

10.1200/JCO.2017.35.15_suppl.3515

Abstract #

3515

Poster Bd #

138

Abstract Disclosures